Profound Medical Corp. (PROF)
PROF Stock Price Chart
Explore Profound Medical Corp. interactive price chart. Choose custom timeframes to analyze PROF price movements and trends.
PROF Company Profile
Discover essential business fundamentals and corporate details for Profound Medical Corp. (PROF) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Devices
IPO Date
29 Oct 2019
Employees
142.00
Website
https://www.profoundmedical.comCEO
Arun Swarup Menawat
Description
Profound Medical Corp., through its subsidiaries, is a commercial-stage medical technology firm specializing in the development of magnetic resonance (MR)-guided ablation solutions. These innovative procedures are designed to treat conditions such as prostate disease and uterine fibroids, as well as providing palliative pain relief. The company markets its solutions across Canada, Germany, the United States, and Finland. Its flagship product, the TULSA-PRO system, is specifically designed for use with magnetic resonance imaging (MRI) scanners within hospital settings and other treatment centers. Additionally, Profound Medical offers Sonalleve, a therapeutic platform that addresses uterine fibroids – including through non-invasive methods – and provides palliative relief for pain linked to bone metastases. The company's primary operations are headquartered in Mississauga, Canada.
PROF Financial Timeline
Browse a chronological timeline of Profound Medical Corp. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 6 Aug 2026
EPS estimate is -$0.22, while revenue estimate is $4.75m.
Earnings released on 7 May 2026
EPS came in at -$0.19 surpassing the estimated -$0.24 by +20.83%, while revenue for the quarter reached $5.34m , beating expectations by +10.00%.
Earnings released on 5 Mar 2026
EPS came in at -$0.27 matching the estimated -$0.27, while revenue for the quarter reached $5.98m , missing expectations by -22.04%.
Earnings released on 13 Nov 2025
EPS came in at -$0.26 surpassing the estimated -$0.38 by +31.58%, while revenue for the quarter reached $5.23m , missing expectations by -50.31%.
Earnings released on 14 Aug 2025
EPS came in at -$0.52 falling short of the estimated -$0.43 by -20.93%, while revenue for the quarter reached $2.21m , missing expectations by -53.29%.
Earnings released on 8 May 2025
EPS came in at -$0.36 falling short of the estimated -$0.29 by -24.14%, while revenue for the quarter reached $2.62m , missing expectations by -44.12%.
Earnings released on 6 Mar 2025
EPS came in at -$0.20 surpassing the estimated -$0.31 by +35.48%, while revenue for the quarter reached $5.33m , missing expectations by -9.99%.
Earnings released on 7 Nov 2024
EPS came in at -$0.38 falling short of the estimated -$0.30 by -26.67%, while revenue for the quarter reached $3.83m , missing expectations by -35.36%.
Earnings released on 8 Aug 2024
EPS came in at -$0.28 surpassing the estimated -$0.29 by +3.45%, while revenue for the quarter reached $2.23m , missing expectations by -13.80%.
Earnings released on 9 May 2024
EPS came in at -$0.26 surpassing the estimated -$0.30 by +13.33%, while revenue for the quarter reached $1.44m , missing expectations by -42.90%.
Earnings released on 7 Mar 2024
EPS came in at -$0.42 falling short of the estimated -$0.32 by -31.25%, while revenue for the quarter reached $2.66m , beating expectations by +36.51%.
Earnings released on 2 Nov 2023
EPS came in at -$0.26 surpassing the estimated -$0.33 by +21.21%, while revenue for the quarter reached $1.73m , missing expectations by -14.46%.
Earnings released on 9 Aug 2023
EPS came in at -$0.35 falling short of the estimated -$0.34 by -2.94%, while revenue for the quarter reached $1.60m , missing expectations by -26.18%.
Earnings released on 10 May 2023
EPS came in at -$0.32 surpassing the estimated -$0.34 by +5.88%, while revenue for the quarter reached $1.86m , missing expectations by -11.84%.
Earnings released on 7 Mar 2023
EPS came in at -$0.46 falling short of the estimated -$0.36 by -27.78%, while revenue for the quarter reached $1.70m , missing expectations by -36.32%.
Earnings released on 3 Nov 2022
EPS came in at -$0.24 surpassing the estimated -$0.38 by +36.84%, while revenue for the quarter reached $2.81m , beating expectations by +16.42%.
Earnings released on 4 Aug 2022
EPS came in at -$0.28 surpassing the estimated -$0.40 by +30.00%, while revenue for the quarter reached $2.01m , missing expectations by -0.40%.
Earnings released on 9 May 2022
EPS came in at -$0.40 surpassing the estimated -$0.43 by +6.98%, while revenue for the quarter reached $1.71m , missing expectations by -2.90%.
Earnings released on 3 Mar 2022
EPS came in at -$0.49 falling short of the estimated -$0.37 by -32.43%, while revenue for the quarter reached $1.26m , missing expectations by -54.76%.
Earnings released on 4 Nov 2021
EPS came in at -$0.29 falling short of the estimated -$0.28 by -3.57%, while revenue for the quarter reached $3.21m , beating expectations by +43.20%.
Earnings released on 4 Aug 2021
EPS came in at -$0.35 falling short of the estimated -$0.28 by -25.00%, while revenue for the quarter reached $2.60m , beating expectations by +1.10%.
PROF Stock Performance
Access detailed PROF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
